MARKET WIRECNBC • 1h ago
Here are 3 big things we're watching in the stock market in the week aheadThe market could use a few victories in the days ahead, which will be filled with more earnings, an election, and jobs data.
Why CDIO Stock surged +2.94% Today — RQD Quant Desk Flash
$1.75 +2.94% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
Cardio Diagnostics Holdings Inc. (CDIO) carries a Roarable Rating of E (Strong Sell) with 31/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE E • RED ALERT
Cap $5.2M
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERRED ALERT • E
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw E · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-12% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CDIO)Realized 20D OHLCV Swing Band: ±12.5%
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why CDIO Stock surged +2.94% Today — RQD Quant Desk Flash
Cardio Diagnostics Holdings Inc. (CDIO) surged +2.94% to $1.75, trading at 11% of its 52-week range ($0.97 – $7.91). Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 11% of its 52-week range ($0.97 – $7.91) with RSI-14 at 41 (NEUTRAL RANGE).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $1.75 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable E (Strong Sell) backed by 52% gross margin and $0 annual free cash flow.
Live CDIO Headlines & Catalysts
MARKET WIRECNBC • 2h ago
Democratic Rep. Stevens endorses Rogers over El-Sayed in Michigan Senate electionHaley Stevens had lost the Democratic nomination for Senate in Michigan to Abdul El-Sayed earlier this year.
RISK WATCHReuters • 3h ago
Israeli strikes kill eight people in Gaza - medics say - ReutersIsraeli strikes kill eight people in Gaza - medics say Reuters
MARKET WIREReuters • 4h ago
Russia's FSB says minor detained over park attack threat after US tip-off - ReutersRussia's FSB says minor detained over park attack threat after US tip-off Reuters
MARKET WIREReuters • 5h ago
Iran, Qatari mediators hold third day of talks to end US-Iran war - ReutersIran, Qatari mediators hold third day of talks to end US-Iran war Reuters
CATALYSTReuters • 6h ago
Qatar surges, bucking Gulf market slide on Iran war concerns - ReutersQatar surges, bucking Gulf market slide on Iran war concerns Reuters
MARKET WIREReuters • 6h ago
OPEC+ keeps December oil output targets steady ahead of tougher call for 2027 - ReutersOPEC+ keeps December oil output targets steady ahead of tougher call for 2027 Reuters
MARKET WIREReuters • 6h ago
German ministers pledge tough action after rioters damage stores in Frankfurt - ReutersGerman ministers pledge tough action after rioters damage stores in Frankfurt Reuters
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CDIO)
- ✓Walkthrough of CDIO's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CDIO // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -2.23%▼ DESCENDING CHANNEL
2026-10-30O $1.72H $1.75L $1.67C $1.75VOL 12.0K
RES: $2.17SUP: $1.48SMA50: $1.87SMA200: $2.07
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
CDIO Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. -57.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on CDIO today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for CDIO. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CDIO today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CDIO)
Health Care Rank #937 of 1016
⚔️ TRIB vs CDIO Full Matrix →
1. Head-to-Head Health Care Peer Comparison (CDIO vs. TRIB, QCLS, BMRA, VRAX)
Industry: Biotechnology: In Vitro & In Vivo Diagnostic Substances (18 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, Cardio Diagnostics Holdings Inc. (CDIO) ranks #937 by composite RQD confidence (31/100, grade E) and #943 by equity capitalization ($5.2M). Within this direct 5-issuer industry benchmark cohort, CDIO leads on earnings valuation at N/A trailing P/E, while CDIO leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. VRAX currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with CDIO at 31/100 (E).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| CDIO
ACTIVE
Cardio Diagnostics Holdings Inc. | E | 31/100 | — | — | -35.0% | +2.94% | $5.2M | Benchmark Subject |
| TRIB Trinity Biotech plc | D+ | 56/100 | — | — | — | -2.50% | $5.4M | /trib-vs-cdio → |
| QCLS Q/C Technologies Inc. | D- | 42/100 | — | — | -35.0% | -3.44% | $3.6M | /qcls-vs-cdio → |
| BMRA Biomerica Inc. | D- | 39/100 | — | 8.1% | -35.0% | -0.57% | $8.0M | /bmra-vs-cdio → |
| VRAX Virax Biolabs Group Limited | D+ | 58/100 | — | — | — | +10.00% | $1.8M | /vrax-vs-cdio → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001870144In its most recent audited fiscal period (FY2025, filed 2025-12-31), Cardio Diagnostics Holdings Inc. (CDIO) reported GAAP revenue of $14.8K (-57.5% vs. FY2024 revenue of $34.9K , and -13.1% cumulative change since FY2023) , GAAP net income of -$6.5M, operating cash flow of -$5.7M, and free cash flow of -$5.9M (-13.6% YoY). On the balance sheet, CDIO closed FY2025 with $7.8M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 3/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-12-31 | $14.8K | -$6.5M | -$5.7M | -$5.9M | $7.8M | — |
| FY2024 (FY) | 2024-12-31 | $34.9K | -$8.4M | -$5.0M | -$5.2M | $10.6M | — |
| FY2023 (FY) | 2023-12-31 | $17.1K | -$8.4M | -$5.7M | -$5.7M | — | — |
3. CDIO Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs CDIO stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-01, Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 31/100 at a spot price of $1.75 (+2.94% 1D, market cap $5.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 12/20, Executive Insider Alignment 3/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, CDIO ranks #937 in composite RQD confidence.
How does CDIO compare to TRIB and QCLS in the Health Care sector?
Within the Health Care sector (Biotechnology: In Vitro & In Vivo Diagnostic Substances), CDIO carries a Roarable E (31/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, TRIB (Trinity Biotech plc) holds a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $5.4M) and QCLS (Q/C Technologies Inc.) posts a D- grade (42/100 RQD, P/E N/A, ROIC -35.0%, cap $3.6M). Among the 5-stock peer group, CDIO leads on earnings multiple (N/A) while CDIO leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for CDIO?
Per CDIO's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001870144), Cardio Diagnostics Holdings Inc. generated $14.8K in revenue (-57.5% YoY), -$6.5M in net income, and -$5.9M in free cash flow against $7.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is CDIO trading relative to its 50-day, 200-day, and 52-week technical levels?
CDIO last traded at $1.75 (+2.94% on volume of 5,717 shares), positioning the stock -6.42% below its 50-day simple moving average ($1.87) and -15.46% below its 200-day simple moving average ($2.07). Across its 52-week range of $0.97 to $7.91, CDIO sits at the 11.2% percentile with a 14-day RSI of 41.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.53 to $1.97).
CDIO Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is CDIO stock moving today?
Why CDIO Stock surged +2.94% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.